Coya Therapeutics Inc (COYA)

10:19 AM

AI in Clinical Trials Market Growth 2025: Trends, Consumer - openPR.com

10:19 AM

04:55 AM

Coya Therapeutics (NASDAQ:COYA) Trading 8.6% Higher – What’s Next? - Defense World

04:55 AM

Apr 21, 2025

Breakthrough: New GLP-1/IL-2 Combo Drug Outperforms Standard Therapy by 42% in Alzheimer's Research - Stock Titan

Apr 21, 2025

Apr 20, 2025

(COYA) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 20, 2025

Apr 11, 2025

Is Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance

Apr 11, 2025

Apr 10, 2025

Coya Therapeutics stock hits 52-week low at $4.72 - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

Coya Therapeutics stock hits 52-week low at $4.72 By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 02, 2025

Exosomes Pipeline 2025: MOA and ROA Insights, Clinical Trials - openPR.com

Apr 02, 2025

Apr 01, 2025

Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025 - The Joplin Globe

Apr 01, 2025

Mar 31, 2025

GMP Production of Exosomes Slated for Later This Year - streetwisereports.com

Mar 31, 2025

Mar 29, 2025

D. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA) - Defense World

Mar 29, 2025

Mar 28, 2025

Biotech Advances Revolutionary Treatment for Neurodegenerative Diseases - Streetwise Reports

Mar 28, 2025

Mar 28, 2025

What is Chardan Capital’s Forecast for COYA FY2025 Earnings? - Defense World

Mar 28, 2025

Mar 27, 2025

What Makes Coya Therapeutics, Inc. (COYA) a New Buy Stock - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Wall Street Analysts Think Coya Therapeutics, Inc. (COYA) Could Surge 149.62%: Read This Before Placing a Bet - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - Yahoo

Mar 27, 2025

Mar 26, 2025

Coya Therapeutics advances Treg exosome production By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Coya Therapeutics advances Treg exosome production - Investing.com India

Mar 26, 2025

Mar 26, 2025

Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program - Joplin Globe

Mar 26, 2025

Mar 26, 2025

Revolutionary Treg Exosome Treatment Could Transform Neurodegenerative Disease Therapy - Stock Titan

Mar 26, 2025

Mar 25, 2025

Agitation in Alzheimer's Disease Market: Analysis - openPR.com

Mar 25, 2025

Mar 24, 2025

(COYA) Trading Report - news.stocktradersdaily.com

Mar 24, 2025

Mar 22, 2025

Coya Therapeutics (NASDAQ:COYA) Earns Buy Rating from Chardan Capital - Defense World

Mar 22, 2025

Mar 21, 2025

Coya Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 21, 2025

Mar 20, 2025

Coya Therapeutics to Present ALS Clinical Study Data for its Investigational Biologic Combination at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. - Business Wire

Mar 20, 2025

Mar 20, 2025

Coya Therapeutics (NASDAQ:COYA) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Mar 20, 2025

Mar 20, 2025

BTIG maintains Buy on Coya Therapeutics, target at $15 By Investing.com - Investing.com Canada

Mar 20, 2025

Mar 19, 2025

Coya Therapeutics’ (COYA) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Mar 19, 2025

Mar 18, 2025

Coya Therapeutics Reports 2024 Financial Results and Updates - TipRanks

Mar 18, 2025

Mar 18, 2025

Coya Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 18, 2025

Mar 18, 2025

Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results - Business Wire

Mar 18, 2025

Mar 15, 2025

Coya Therapeutics, Inc. Announces Closing of $15.25 Million Initial Public Offering - Business Wire

Mar 15, 2025

Mar 15, 2025

Coya Therapeutics Announces Closing of $26.5 Million Private Placement - Business Wire

Mar 15, 2025

Mar 14, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 14, 2025

Mar 13, 2025

Where are the Opportunities in (COYA) - Stock Traders Daily

Mar 13, 2025

Mar 11, 2025

Coya Therapeutics (COYA) to Release Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 11, 2025

D. Boral Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA) - The AM Reporter

Mar 11, 2025

Mar 11, 2025

Coya Therapeutics’ (COYA) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Mar 11, 2025

Mar 10, 2025

Market Watch Highlights: Coya Therapeutics Inc (COYA) Ends on an Upturn Note at 6.88 - The Dwinnex

Mar 10, 2025

Mar 08, 2025

EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases - MSN

Mar 08, 2025

Mar 06, 2025

ALS drug failures and why COYA 302 is different - Digital Journal

Mar 06, 2025

Mar 04, 2025

Coya Therapeutics (NASDAQ:COYA) Trading Up 4.5% – Should You Buy? - Defense World

Mar 04, 2025

Mar 03, 2025

(COYA) Investment Analysis - Stock Traders Daily

Mar 03, 2025

Feb 25, 2025

Can GLP-1 Agonists Transform Alzheimer's Treatment? Coya Therapeutics Experts Weigh In - StockTitan

Feb 25, 2025

Feb 22, 2025

Coya reports promising Alzheimer's treatment study results - MSN

Feb 22, 2025

Feb 20, 2025

Long Term Trading Analysis for (COYA) - Stock Traders Daily

Feb 20, 2025

Feb 20, 2025

Robust Growth in AI in Clinical Trials Market (2025-2032): - openPR

Feb 20, 2025

Feb 14, 2025

Newbridge Financial Services Group Inc. Makes New Investment in Coya Therapeutics, Inc. (NASDAQ:COYA) - MarketBeat

Feb 14, 2025